• Publications
  • Influence
Clinical and Laboratory Predictors of Distinct Histopathogical Features of Lupus Nephritis
AbstractThe authors aimed to explore whether distinct clinical, serological, and urinalysis findings are associated with specific histological classes of lupus nephritis. Clinical and laboratoryExpand
  • 28
  • 2
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic
Autoimmune diseases are a complex set of diseases characterized by immune system activation and, although many progresses have been done in the last 15years, several unmet needs in the management ofExpand
  • 79
  • 1
Cancer diagnosis in a cohort of patients with Sjogren's syndrome and rheumatoid arthritis: a single-center experience and review of the literature.
BACKGROUND With the development of modern therapies and better care of patients with autoimmune rheumatic diseases (ARDs) increased survival has been achieved. However, ARDs may share an associationExpand
  • 9
  • 1
Tuberculous pyomyositis in a rheumatoid arthritis patient treated with anakinra.
Musculoskeletal tuberculosis (TB) occurs in only 3% of patients with TB while tuberculous pyomyositis is rare. It usually affects immunocompromised or patients with underlying comorbidities. WeExpand
  • 9
Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis.
OBJECTIVES Prompt, aggressive therapy is vital for anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. In this regard, we aimed to identify predictors of distinct renalExpand
  • 4
Sjögren Syndrome Associated with Inflammatory Muscle Diseases
Objectives: Sjögren’s syndrome (SS) is a chronic autoimmune inflammatory disorder characterized by diminished lacrimal and salivary gland function that may affect multiple organ systems. TheExpand
  • 4
  • PDF
FRI0179 Infliximab infusion reactions in patients with rheumatoid arthritis and spondylarthropathies
Background Therapies that target TNF have been successfully used for the treatment of patients with rheumatoid arthritis (RA) and spondylarthropathies (SpA). TNF-α blocking agents have beenExpand
AB0123 Antibodies to Porphyromonas Gingivalis in Patients with Rheumatoid Arthritis
Background Rheumatoid arthritis (RA) is characterized by antibodies to citrullinated protein antigens (ACPA). Porphyromonas gingivalis (PG) is a major pathogen in periodontitis which possesses aExpand